A Healthier Future

Advancing Regenerative Medicine

Trusted Worldwide By Leading

OBGYN & Transplant Physicians

Therapeutic Pioneers

Saving And Improving The Quality Of Lives Is Our Mission

StemCyte collaborates with the most prestigious research centers and academic institutions in neuroscience. Our first and most advanced regenerative clinical trial project aims to treat patients suffering from spinal cord injury, which is FDA approved for a Phase II IND for cord blood use.

StemCyte’s rich history started with a mission of being dedicated to helping the world’s physicians save more lives by providing high quality, safe and effective stem cell transplantation and therapy to all patients in need.

Proven Experience

Deliver The Most Transplant Units

Our transplant success has a lot to do with why leading OBGYNs and transplant physicians refer their patients to bank with StemCyte. Among privately-owned cord blood banks, we ship the most cord blood transplant units to over 350 transplant centers around the world.

As of June 30, 2019, we are proud to deliver a successful transplant unit, which was stored for 17 years. That’s quality.

Our Guarantees

StemCyte Is The Only Cord Blood Bank
Offering These Guarantees.

LifeSaver Guarantee

What happens if your banked cord blood does not engraft? Don't worry, we have you covered with our LifeSaver Guarantee.

  • Free replacement from our public inventory
  • Additional $50,000
  • Refund all fees

StemCyte Care

What happens if your banked cord blood is deemed ineligible by the transplant physician because you don't have enough volume collected, TNC amount is low, have congenital diseases, or have sterility issues? Don't worry, we've got you covered with StemCyte Care!

  • Receive additional unit from our public inventory
  • Expand search internationally and pay up to $50,000
  • Additional $80,000 towards medical costs

*Terms and conditions apply.

Processing Technology

StemCyte offers two methods to preserve your newborn’s cord blood stem cells:

StandardCell® or MaxCell®. While the industry uses the StandardCell®, we developed our proprietary method of processing where only the plasma layer is removed.

Research studies show that this method yields a higher recovery of TNC (Total Nucleated Cells).

The higher the TNC, the greater the chance of successful transplant and recovery.


(Red Cell Reduction)

  • Most commonly used method
  • Plasma and majority of red cells are removed
  • The final volume is approximately 25mL
  • Preverves less TNC (Total nucleated Cell)


( Plasma Depletion )

  • Only plasma is removed
  • The final volume is approximately 30-80mL.
  • Preserves more TNC (Total nucleated Cell)
  • Quicker recovery rate (references: 1.Bone Marrow Transplantation (2012) 47, 33-39, 2.Bio Blood Transplant (2011) 17, 1375-1382​
  • Higher survival rate (references: Sarah Nikiforow, et. Al. 122 Blood (2013)

Our Accreditations

StemCyte Is Proud Of Our Accreditations

We provide the highest quality standards.

Our Partnership

StemCyte Is Fulfilling Its Mission:

To have the most significant number of high quality and most diverse public cord blood in inventory.


StemCyte was the only private company chosen by HRSA (Health Resources and Services Administration) to help build a national cord blood inventory.

UC Davis

(California Umbilical Cord Blood Collection Program)

We have also been chosen to collaborate with UC Davis Health to increase the number of high quality and racially diverse public cord blood units.

As of September 2019, there are 48 cord blood transplant units funded by California Umbilical Cord Blood Collection Program. We are proud that 46 out of the 48 were collected by StemCyte.

Bank With The Most Trusted Cord Blood Bank!